News Releases

Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial

February 18, 2025

Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview

February 14, 2025

Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum

February 11, 2025

Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention

February 4, 2025

Anixa Biosciences CEO Provides Letter to Shareholders

January 21, 2025

Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10

December 4, 2024

Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

November 22, 2024

Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial

November 18, 2024

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 8, 2024

Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 6, 2024

1
2
3
4
5
6
7
8
9
10
...27
Next »

Latest News & Events

Feb 18, 2025

Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial

Read More...

Feb 14, 2025

Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview

Read More...

Feb 11, 2025

Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum

Read More...